For example, studies in prostate cancer [65-70], renal cell carcinoma [71], liver cancer [72], and breast cancer [73-75] have shown that AR activation can suppress cell proliferation, migration, and metastasis or induce apoptosis and differentiation programs counteracting malignant phenotypes. Here, AR is linked to breast cancer.